Fischer Medical Ventures Complete Financial Statements
In FY2025, Fischer Medical Ventures (FISCHER) reported revenue ₹89 Cr, net profit ₹14 Cr and EPS ₹0.22, with a net profit margin of 15.7% and ROE of 4.1%. Full financial statements from FY2023 to FY2025 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see FISCHER stock live price.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
FISCHER Revenue, Net Profit & EBITDA — Year-on-Year Growth
FISCHER YoY (Sept 2024 vs Sept 2025) — revenue +122.5%, EBITDA +1800.0%, expenses +79.5%.
FISCHER Income Statement — Revenue, EBITDA & Net Profit
Fischer Medical Ventures revenue ₹89 Cr, EBITDA ₹19 Cr, net profit ₹14 Cr, EPS ₹0.22 (2025) — net profit margin 15.7%. Explore Fischer Medical Ventures intrinsic worth to estimate fundamental worth using multiple valuation models.
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Jun 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 89 | 49 | 31 | 102 | 40 | 21 | 11 | 12 | 0 | 0 | 0 |
| Expenses | 70 | 47 | 19 | 80 | 39 | 18 | 10 | 11 | 0 | 0 | 1 |
| EBITDA | 19 | 3 | 12 | 23 | 1 | 3 | 1 | 1 | 0 | 0 | -1 |
| Operating Profit Margin % | 19.00% | 5.00% | 18.00% | 21.00% | 1.00% | 12.00% | -3.00% | 3.00% | 0.00% | 0.00% | -347.00% |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 17 | 2 | 10 | 21 | 0 | 3 | 0 | 0 | 0 | 0 | -1 |
| Tax | 3 | 1 | 5 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 14 | 1 | 5 | 19 | 0 | 3 | 0 | 0 | 0 | 0 | -1 |
| Earnings Per Share (₹) | 0.22 | -0.05 | 0.77 | 0.30 | 0.05 | 0.48 | 0.65 | -0.05 | 0.00 | 0.00 | 0.00 |
FISCHER Balance Sheet — Assets, Liabilities & Shareholders' Equity
FISCHER total assets ₹457 Cr, total equity ₹338 Cr, total liabilities ₹ Cr (2025) — ROE 4.1%.
| Particulars | 2025 | 2024 | 2023 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 457 | 86 | 0 |
| Current Assets | 365 | 70 | 0 |
| Fixed Assets | 24 | 15 | 0 |
| Capital Work in Progress | 1 | 0 | 0 |
| Investments | 11 | 1 | 0 |
| Other Assets | 422 | 70 | 0 |
| LIABILITIES | |||
| Total Liabilities | |||
| Current Liabilities | 18 | 1 | 1 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 338 | 81 | 0 |
| Share Capital | 64 | 54 | 0 |
| Reserves & Surplus | 244 | 27 | 0 |
FISCHER Cash Flow Statement — Operating, Investing & Financing
Fischer Medical Ventures operating cash flow ₹-87 Cr, investing ₹-125 Cr, financing ₹315 Cr, net cash flow ₹103 Cr (2025).
| Particulars | March 2025 | March 2024 |
|---|---|---|
| Operating Activities | -87 | -7 |
| Investing Activities | -125 | -29 |
| Financing Activities | 315 | 37 |
| Net Cash Flow | 103 | 1 |